Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of ceftiofur after a single intravenous, subcutaneous and subcutaneous-LA administration in lactating goats

被引:0
|
作者
Emilio Fernández-Varón
Carlos Cárceles-García
Juan Manuel Serrano-Rodríguez
Carlos M. Cárceles-Rodríguez
机构
[1] University of Murcia,Department of Pharmacology, Faculty of Veterinary Medicine
[2] University of Cordoba,Department of Pharmacology, Toxicology and Legal and Forensic Medicine, Faculty of Veterinary Medicine
来源
关键词
Ceftiofur; Pharmacokinetic/Pharmacodynamic; Long-acting formulation; Lactating goats;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Pharmacokinetics (PK) and pharmacodynamics (PD) of weekly and tiw subcutaneous doses of recombinant human erythropoietin in healthy subjects.
    Cheung, WC
    Wacholtz, MC
    Young, DC
    BLOOD, 1997, 90 (10) : 3547 - 3547
  • [22] Single-dose safety, pharmacokinetics (PK) and pharmacodynamics (PD) of fexinidazole
    Tarral, A.
    Blesson, S.
    Valverde, O.
    Hovsepian, L.
    Even, E.
    Strub-Wourgaft, N.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2011, 16 : 176 - 176
  • [23] Influence of release rate, dose and co-administration on pharmacokinetics, pharmacodynamics and PK-PD relationship of tanshinone IIA and tanshinol
    Li, Zhenghua
    Li, Ziyi
    Wang, Bingwei
    Liu, Jianping
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 168
  • [24] Multiorgan-on-a-chip for cancer drug pharmacokinetics-pharmacodynamics (PK-PD) modeling and simulations
    Mohammed, Abdurehman Eshete
    Kurucaovali, Filiz
    Okvur, Devrim Pesen
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2025, 52 (01)
  • [25] Lansoprazole suspension pharmacokinetics-pharmacodynamics (PK-PD) in critically ill pediatric patients.
    DiGiacinto, J
    Graumlich, JF
    Bysani, GK
    Torres, A
    Shushunov, S
    Kastrissios, H
    Scheibel, LW
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 104 - 104
  • [26] Denosumab pharmacokinetics (PK) and pharmacodynamics (PD) after various multiple subcutaneous (SC) dosing regimens in postmenopausal women with low bone mass
    Peterson, M. C.
    Stouch, B. J.
    Martin, S. W.
    Miller, P. D.
    McClung, M. R.
    Fitzpatrick, L.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S38 - S38
  • [27] Pharmacokinetics and pharmacodynamics (PK/PD) of irbesartan in Beagle dogs after oral administration at two dose rates
    Carlucci, L.
    Song, K. H.
    Yun, H. I.
    Park, H. J.
    Seo, K. W.
    Giorgi, M.
    POLISH JOURNAL OF VETERINARY SCIENCES, 2013, 16 (03): : 555 - 561
  • [28] PHARMACOKINETICS OF SPIRAMYCIN AFTER INTRAVENOUS, INTRAMUSCULAR AND SUBCUTANEOUS ADMINISTRATION IN LACTATING COWS
    SANDERS, P
    MOULIN, G
    GUILLOT, P
    DAGORN, M
    PERJANT, P
    DELEPINE, B
    GAUDICHE, C
    MOUROT, D
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1992, 15 (01) : 53 - 61
  • [29] Carbamazepine (CBZ) pharmacokinetics-pharmacodynamics (PK-PD) in genetically epilepsy-prone rats (GEPRs).
    Graumlich, JF
    McLaughlin, RG
    Birkhahn, DK
    Shah, N
    Buck, A
    Jobe, PC
    Dailey, JW
    FASEB JOURNAL, 1999, 13 (05): : A810 - A810
  • [30] PHARMACOKINETICS PHARMACODYNAMICS (PK-PD) RELATIONSHIPS OF MIZOLASTINE, A NEW NON SEDATIVE H-1 ANTIHISTAMINE
    ROSENZWEIG, P
    CABANIS, MJ
    DUBRUC, C
    ULLIAC, N
    THEBAULT, JJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (02) : 170 - 170